In this study, we characterized the epigenomic landscape of endothelial cell senescence and found that the core transcription factor FOXP1 regulated by super-enhancers can delay endothelial cell senescence, alleviate endothelial dysfunction and atherosclerosis. Here, FOXP1 is linked to endothelial dysfunction.